These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17448659)

  • 41. Thyroid receptor ligands. Part 7: Indirect antagonists of the thyroid hormone receptor with improved affinity.
    Malm J; Gordon S; Brandt P; Carlsson B; Agback P; Bäckbro Saeidi A; Sandberg J
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2018-21. PubMed ID: 17254783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The melanin-concentrating hormone system and its physiological functions.
    Saito Y; Nagasaki H
    Results Probl Cell Differ; 2008; 46():159-79. PubMed ID: 18227983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, and structure-activity relationship of novel CCR2 antagonists.
    Kothandaraman S; Donnely KL; Butora G; Jiao R; Pasternak A; Morriello GJ; Goble SD; Zhou C; Mills SG; Maccoss M; Vicario PP; Ayala JM; Demartino JA; Struthers M; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1830-4. PubMed ID: 19237282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
    Jin J; An M; Sapienza A; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Salyers KL; Knight SD; Keenan RM; Rivero RA; Dhanak D; Douglas SA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3950-4. PubMed ID: 18573659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists.
    Vasudevan A; Souers AJ; Freeman JC; Verzal MK; Gao J; Mulhern MM; Wodka D; Lynch JK; Engstrom KM; Wagaw SH; Brodjian S; Dayton B; Falls DH; Bush E; Brune M; Shapiro RD; Marsh KC; Hernandez LE; Collins CA; Kym PR
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5293-7. PubMed ID: 16203136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
    Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.
    Ando M; Sekino E; Haga Y; Moriya M; Ito M; Ito J; Iwaasa H; Ishihara A; Kanatani A; Ohtake N
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5186-90. PubMed ID: 19632840
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Melanin-concentrating hormone receptor 1 antagonists: synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives.
    Kasai S; Kamaura M; Kamata M; Aso K; Ogino H; Nakano Y; Watanabe K; Kaisho T; Tawada M; Nagisa Y; Takekawa S; Kato K; Suzuki N; Ishihara Y
    Bioorg Med Chem; 2011 Nov; 19(21):6261-73. PubMed ID: 21975069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists.
    Balog A; Salvati ME; Shan W; Mathur A; Leith LW; Wei DD; Attar RM; Geng J; Rizzo CA; Wang C; Krystek SR; Tokarski JS; Hunt JT; Gottardis M; Weinmann R
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6107-11. PubMed ID: 15546739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4859-63. PubMed ID: 18682323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
    Lim CJ; Kim N; Lee EK; Lee BH; Oh KS; Yoo SE; Yi KY
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2309-12. PubMed ID: 21420863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1.
    Kanuma K; Omodera K; Nishiguchi M; Funakoshi T; Chaki S; Semple G; Tran TA; Kramer B; Hsu D; Casper M; Thomsen B; Sekiguchi Y
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3853-6. PubMed ID: 16002290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of a novel series of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
    Mihalic JT; Chen X; Fan P; Chen X; Fu Y; Liang L; Reed M; Tang L; Chen JL; Jaen J; Li L; Dai K
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7001-5. PubMed ID: 22019296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The discovery of biaryl carboxamides as novel small molecule agonists of the motilin receptor.
    Westaway SM; Brown SL; Conway E; Heightman TD; Johnson CN; Lapsley K; Macdonald GJ; MacPherson DT; Mitchell DJ; Myatt JW; Seal JT; Stanway SJ; Stemp G; Thompson M; Celestini P; Colombo A; Consonni A; Gagliardi S; Riccaboni M; Ronzoni S; Briggs MA; Matthews KL; Stevens AJ; Bolton VJ; Boyfield I; Jarvie EM; Stratton SC; Sanger GJ
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6429-36. PubMed ID: 19006669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4268-73. PubMed ID: 19500979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists.
    Humphries PS; Benbow JW; Bonin PD; Boyer D; Doran SD; Frisbie RK; Piotrowski DW; Balan G; Bechle BM; Conn EL; Dirico KJ; Oliver RM; Soeller WC; Southers JA; Yang X
    Bioorg Med Chem Lett; 2009 May; 19(9):2400-3. PubMed ID: 19346127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 2.
    Vasudevan A; Wodka D; Verzal MK; Souers AJ; Gao J; Brodjian S; Fry D; Dayton B; Marsh KC; Hernandez LE; Ogiela CA; Collins CA; Kym PR
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4879-82. PubMed ID: 15341943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New amide derivatives as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
    Cirauqui N; Ceras J; Galiano S; Pérez-Silanes S; Juanenea L; Rivera G; Aldana I; Monge A
    Arzneimittelforschung; 2008; 58(11):585-91. PubMed ID: 19137910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.
    Betschmann P; Bettencourt B; Donnelly-Roberts D; Friedman M; George J; Hirst G; Josephsohn N; Konopacki D; Li B; Maull J; Morytko MJ; Moore NS; Namovic M; Rafferty P; Salmeron-Garcia JA; Tarcsa E; Wang L; Woller K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3848-51. PubMed ID: 18595695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.
    McBriar MD; Guzik H; Xu R; Paruchova J; Li S; Palani A; Clader JW; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar B; Weig B
    J Med Chem; 2005 Apr; 48(7):2274-7. PubMed ID: 15801820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.